Key facts
- Vena Vitals’s last known valuation is $30.0M (Mar 2025).
- It has raised $2.1M; the latest was Seed Round ($1.9M) in Mar 2025.
- Notable investors include Y Combinator, US National Science Foundation, Soma Capital, MedTech Innovator, Samsung NEXT Ventures — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Vena Vitals
- ·The full record, as it builds
Funding rounds
No funding rounds for Vena Vitals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vena Vitals
Developer of a small sticker designed to monitor blood pressure continuously. The company's platform has the potential to revolutionize the way blood pressure is monitored and managed, enabling healthcare professionals to improve the quality of care for people with hypertension and other cardiovascular diseases.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2019
- Employees
- 14
- Website
- venavitals.com/
- Ownership
- Privately Held (backing)
Vena Vitals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vena Vitals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vena Vitals in its N-PORT filings yet. We sweep new filings monthly.